pioglitazone has been researched along with carbachol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajwa, PJ; Lee, JW; Lytle, C; Straus, DS | 1 |
| Abd-Elrahman, KS; Abdel-Galil, AG; El-Gowelli, HM; El-Mas, MM; Saad, EI | 1 |
2 other study(ies) available for pioglitazone and carbachol
| Article | Year |
|---|---|
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Topics: Administration, Oral; Animals; Calcium; Carbachol; Chlorides; Cholera Toxin; Colforsin; Colon; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Electric Impedance; Female; Gastrointestinal Agents; HT29 Cells; Humans; Ileum; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Intestinal Secretions; Intestines; Jejunum; KCNQ1 Potassium Channel; Mice; Pioglitazone; PPAR gamma; Rosiglitazone; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Thiazolidinediones; Time Factors | 2009 |
Role of PPAR gamma/nitric oxide synthase signaling in the cyclosporine-induced attenuation of endothelium-dependent renovascular vasodilation.
Topics: Anilides; Animals; Arginine; Carbachol; Cyclosporine; Endothelium-Dependent Relaxing Factors; Immunosuppressive Agents; In Vitro Techniques; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylephrine; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Signal Transduction; Thiazolidinediones; Vasoconstrictor Agents; Vasodilation | 2010 |